1. Home
  2. ANVS vs SFWL Comparison

ANVS vs SFWL Comparison

Compare ANVS & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • SFWL
  • Stock Information
  • Founded
  • ANVS 2008
  • SFWL 2001
  • Country
  • ANVS United States
  • SFWL China
  • Employees
  • ANVS N/A
  • SFWL N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • SFWL Trucking Freight/Courier Services
  • Sector
  • ANVS Health Care
  • SFWL Industrials
  • Exchange
  • ANVS Nasdaq
  • SFWL Nasdaq
  • Market Cap
  • ANVS 92.6M
  • SFWL 80.8M
  • IPO Year
  • ANVS 2020
  • SFWL 2023
  • Fundamental
  • Price
  • ANVS $2.95
  • SFWL $1.02
  • Analyst Decision
  • ANVS Strong Buy
  • SFWL
  • Analyst Count
  • ANVS 6
  • SFWL 0
  • Target Price
  • ANVS $29.67
  • SFWL N/A
  • AVG Volume (30 Days)
  • ANVS 548.9K
  • SFWL 20.5K
  • Earning Date
  • ANVS 03-31-2025
  • SFWL 03-27-2025
  • Dividend Yield
  • ANVS N/A
  • SFWL N/A
  • EPS Growth
  • ANVS N/A
  • SFWL N/A
  • EPS
  • ANVS N/A
  • SFWL 0.11
  • Revenue
  • ANVS N/A
  • SFWL $446,281,000.00
  • Revenue This Year
  • ANVS N/A
  • SFWL N/A
  • Revenue Next Year
  • ANVS N/A
  • SFWL N/A
  • P/E Ratio
  • ANVS N/A
  • SFWL $9.47
  • Revenue Growth
  • ANVS N/A
  • SFWL 14.80
  • 52 Week Low
  • ANVS $2.88
  • SFWL $0.81
  • 52 Week High
  • ANVS $20.00
  • SFWL $2.23
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 20.82
  • SFWL 46.64
  • Support Level
  • ANVS $2.99
  • SFWL $0.98
  • Resistance Level
  • ANVS $5.50
  • SFWL $1.08
  • Average True Range (ATR)
  • ANVS 0.34
  • SFWL 0.05
  • MACD
  • ANVS -0.18
  • SFWL 0.00
  • Stochastic Oscillator
  • ANVS 3.59
  • SFWL 48.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. The company offers contract logistics services comprising planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The integrated logistics solution services of the company are comprised of three segments: B2B freight transportation; cloud storage; and value-added services.

Share on Social Networks: